SCHEMBL24608908

SCHEMBL24608908

c1ccc(-c2ccc3c(c2)-c2ccc(-c4cc(-c5ccc6c(c5)-c5ccccc5-c5ccccc5-c5ccccc5-6)cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)cc2C32C3CC4CC(C3)CC2C4)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
THRB P10828 1/20 0.35
XBP1 P17861 1/20 0.35
PTBP1 P26599 1/20 0.35
RAB9A P51151 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
SMAD3 P84022 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23177452 0.97 MEN1 (0.37) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608821 0.97 MEN1 (0.37) MEN1MAPTKMT2AHTTLMNA
SCHEMBL23177457 0.96 MEN1 (0.36) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608840 0.96 PDK2 (0.34) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608827 0.93 PDK2 (0.39) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608777 0.93 PDK2 (0.39) MEN1MAPTKMT2AHTTLMNA
SCHEMBL23177453 0.93 PDK2 (0.39) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608737 0.93 PDK2 (0.39) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24608774 0.93 PDK2 (0.39) MEN1MAPTKMT2AHTTLMNA
SCHEMBL24618074 0.93 MEN1 (0.39) MEN1MAPTKMT2AHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11495748-B2 Organic compound having adamantyl fluorene ligands on 1,3,5-triazine and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-11-08 US disclosed
US-20220216420-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11495748-B2 Organic compound having adamantyl fluorene ligands on 1,3,5-triazine and electronic device OCIAD2, OCIAD1, TRPA1 MEN1 2033/4885MAPT 2147/4885KMT2A 3260/4885
US-20220216420-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE OCIAD2, OCIAD1, PIEZO1 MEN1 2036/4885MAPT 1194/4885KMT2A 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.